Phreesia Inc. (PHR) PT Raised to $31 at Baird
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Purpose Investments Inc. Announces March 2024 Distributions
March 15, 2024 7:30 PM EDTTORONTO, March 15, 2024 (GLOBE NEWSWIRE) -- Purpose Investments Inc. (Purpose) is pleased to announce distributions for the month of March 2024 for its open-end exchange-traded funds and closed-end funds (the Funds).
The ex-distribution date for all ETFs is March 25, 2024, with the exception of Purpose Bitcoin Yield ETF and Purpose Ether Yield ETF, which will have an ex-distribution date of March 26, 2024, as well as Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund which have an ex-distribution date of March 27, 2024. The ex-distribution date for all closed-end funds is March 27, 2024.
... MorePhreesia Announces Fourth Quarter Fiscal 2024 Results
March 14, 2024 4:03 PM EDTWILMINGTON, Del.--(BUSINESS WIRE)-- Phreesia, Inc. (NYSE: PHR) (Phreesia or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2024.
"Phreesia ended fiscal year 2024 with strong momentum going into fiscal 2025. We facilitated more than 150 million patient visits in fiscal 2024, or more than one in ten patient visits across the U.S. We are confident that our solutions and our team position us for continued growth and a return to profitability1," said CEO and Co-Founder Chaim Indig.
Please visit the Phreesia investor relations... More
